• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Hurricane Helene: Impact of IV fluid shortage on patients

Hurricane Helene: Impact of IV fluid shortage on patients

by Truveta Research | Oct 25, 2024 | Research, Research Insights

For patients coming into the emergency department (ED) with nausea/vomiting or dehydration, patients are half as likely to receive IV fluids starting 10 days after the hurricane compared to prior to Hurricane Helene. We expect these numbers to continue to decrease. ...
GLP-1 RA prescription trends: January 2018 – September 2024

GLP-1 RA prescription trends: January 2018 – September 2024

by Truveta staff | Oct 14, 2024 | Research

Overall prescribing rates for GLP-1 medications increased in September 2024 relative to June 2024 (+11.9%). While the rate of GLP-1 prescriptions labeled for type 2 diabetes were about the same as June 2024 (+4.0%), the rate of prescriptions for GLP-1 medications...
Advancing orthopedics: How device-level data is shaping the future of knee, hip, and shoulder replacements

Advancing orthopedics: How device-level data is shaping the future of knee, hip, and shoulder replacements

by Truveta staff | Oct 10, 2024 | Research

The US market size for joint replacement is projected to balloon to nearly $38 billion by 2030, nearly doubling its 2022 value. The combination of an aging population, increasing rates of osteoarthritis and obesity, along with advancing technology, are all...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024

Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024

by Truveta staff | Sep 19, 2024 | Research

Overall, the rate of hospitalizations associated with respiratory viruses remained stable throughout August 2024, with no change compared to July 2024. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased significantly...
Top 10 reasons to choose Truveta’s mother-child EHR dataset

Top 10 reasons to choose Truveta’s mother-child EHR dataset

by Truveta staff | Sep 13, 2024 | Research

Mother and child health are inherently interconnected, offering unique insights into how maternal health, behaviors, and exposures impact child outcomes. Unfortunately, the potential of this data has historically been limited by challenges in data collection, the long...
Real-time monitoring of viral gastroenteritis: August 2024

Real-time monitoring of viral gastroenteritis: August 2024

by Truveta staff | Sep 11, 2024 | Research

The overall trends of hospitalizations associated with viral gastroenteritis – norovirus and rotavirus – show a steady decrease over the last few months, leading to a rate of 0.04% in August 2024 in the overall population. However, we see first indicators that the...
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-world evidence on heart failure from GLP-1 and advanced CKD populations
  • Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval
  • Use of GLP-1 RAs following label expansion for patients with CVD and overweight or obesity

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.